Brain cancer prediction, particularly in pediatric populations, represents a significant advancement in medical science, leveraging innovative technologies such as AI and machine learning.Recent research at Mass General Brigham showcased how an AI tool analyzing MRI scans can more accurately assess the risk of glioma relapse compared to traditional screening methods.